child |
TDLo |
intravenous |
2550mg/kg/17D (2550mg/kg) |
blood: agranulocytosis |
Journal of Pediatrics. Vol. 90, Pg. 668, 1977. |
guinea pig |
LD50 |
unreported |
120mg/kg (120mg/kg) |
|
Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 42(9), Pg. 10, 1977. |
infant |
TDLo |
intravenous |
3800mg/kg/19D (3800mg/kg) |
blood: agranulocytosis |
Journal of Pediatrics. Vol. 89, Pg. 769, 1976. |
man |
TDLo |
intravenous |
3800mg/kg/19D (3800mg/kg) |
blood: agranulocytosis |
Journal of Pediatrics. Vol. 89, Pg. 769, 1976. |
mouse |
LD50 |
intravenous |
1490mg/kg (1490mg/kg) |
|
Pharmaceutical Chemistry Journal Vol. 1, Pg. 245, 1967. |
mouse |
LD50 |
oral |
6500mg/kg (6500mg/kg) |
|
"Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 95, 1982. |
mouse |
LD50 |
unreported |
28gm/kg (28000mg/kg) |
|
Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 42(9), Pg. 10, 1977. |
rat |
LD50 |
unreported |
10gm/kg (10000mg/kg) |
|
Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 42(9), Pg. 10, 1977. |
women |
TDLo |
intravenous |
40mg/kg/7H-I (40mg/kg) |
skin and appendages (skin): "dermatitis, other: after systemic exposure" |
Annals of Pharmacotherpy. Vol. 33, Pg. 1060, 1999. |
women |
TDLo |
intravenous |
5560mg/kg/20D (5560mg/kg) |
blood: agranulocytosis |
Southern Medical Journal. Vol. 70, Pg. 1245, 1977. |
women |
TDLo |
oral |
200mg/kg/10D- (200mg/kg) |
gastrointestinal: other changes |
Southern Medical Journal. Vol. 77, Pg. 532, 1984. |